HCA Healthcare, Inc. (HCA)
Healthcare · Medical - Care Facilities · Data as of 2026-09-01
Bottom line
HCA is trading at a discount to its history, near its historical support zone, and recent volume shows no clear direction. Historically, this combination has been a favourable starting point for further research. Past patterns are not a guarantee of future results.
Valuation — Trading at a discount to its history (Green)
HCA trades at 14× earnings, roughly in line with its own 5-year average of 14× and below similar healthcare companies we track (29×, 52 peers). Historically this has been on the cheaper side for the stock. It also generates strong cash: a free-cash-flow yield of about 7%. Its current multiple sits around the 44th percentile of its own last five years — around the middle of its own range. Its fundamentals scored 7 of 9 on a standard year-over-year quality checklist — most of the underlying trends improved last fiscal year.
Price zones — Near its historical support zone (Green)
At $413.58, the stock is close to the lower end of its recent range. Over the past year HCA has traded between $353.99 and $556.52; its historical support zone sits near $401.79 and resistance near $453.03. It is above one of its moving averages and below the other — a mixed trend picture.
52-week range $353.99–$556.52 · 50-day average $401.79 · 200-day average $453.03
Money flow — No clear direction (Yellow)
Buying and selling volume in HCA have been fairly balanced recently, with no strong accumulation or distribution pattern. Volume on up days has been about 1.2× volume on down days over the last 30 sessions.
About the company
HCA Healthcare, Inc., operating through its subsidiaries, delivers a comprehensive array of healthcare services throughout the United States. The organization manages a network of general and acute care hospitals that provide a full spectrum of medical and surgical care, encompassing inpatient services, intensive care, cardiac treatment, diagnostic procedures, and emergency services. These hospitals additionally offer a broad range of outpatient care, such as ambulatory surgery, laboratory testing, radiology, respiratory therapy, cardiology, and physical therapy.
一句话结论
HCA 相对自身历史处于折价水平，接近其历史支撑区，近期成交量没有明确方向。从历史来看，这样的组合是一个值得进一步研究的有利起点。过去的形态并不能保证未来的结果。
估值 — 相对自身历史处于折价水平
HCA 目前的市盈率为 14×，大致持平于其自身 5 年平均的 14×，并且低于我们追踪的同类Healthcare公司（29×，52 家）。从历史来看，这属于该股较便宜的一侧。它同时产生充沛的现金：自由现金流收益率约为 7%。它当前的估值倍数大约位于自身过去五年分布的第 44 百分位——处于自身区间的中部。在一套标准的逐年基本面核对清单上，它 9 项中通过了 7 项——上一财年多数底层趋势在改善。
价格区间 — 接近其历史支撑区
目前价格为 $413.58，接近其近期区间的下沿。过去一年 HCA 的价格在 $353.99 到 $556.52 之间波动；其历史支撑区在 $401.79 附近，阻力区在 $453.03 附近。它位于其中一条均线上方、另一条下方——趋势信号并不一致。
资金流向 — 方向不明确
HCA 近期的买卖成交量大致均衡，没有明显的吸筹或派发形态。过去 30 个交易日，上涨日的成交量约为下跌日的 1.2×。
UnderTheLight 用直白的语言解释股票——估值、价格区间与资金流向。它只描述数据，不构成任何投资建议。
UnderTheLight explains stocks in plain English — valuation, price zones and money flow as traffic lights, recomputed nightly. It describes data; it is not investment advice and never recommends a trade.